In the present research, we sought to study the role of inflammation by comparing the levels of inflammatory biomarkers (hs‐CRP, IL‐6, and sCD‐40L) in rheumatic mitral stenosis (Rh‐MS) patients with and without AF. Here, IL6 is linked to myeloid sarcoma.